HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
Clinical trial NCT05233358 · UNKNOWN
Trial details
- NCT number
- NCT05233358
- Sponsor
- The Central Hospital of Lishui City
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-02-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.